You can find the annual or quarterly income statement of Breathe BioMedical Ord Shs (Proposed) here for insights into the performance and operational efficiency of Breathe BioMedical Ord Shs (Proposed).
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q1
FY2023Q1
Operating expenses
--2.58M
--1.37M
R&D expenses
--415.10K
--630.21K
Depreciation, depletion, and amortization
--96.52K
--92.79K
Operating profit
---2.58M
---1.37M
Net non-operating interest income (expenses)
Non-operating interest income
----
--4.73K
Non-operating interest expense
--7.70K
----
Gains from sale of securities
--4.07K
--4.79K
Other non-operating income (expenses)
--162.74K
--206.74K
Income before tax
---2.42M
---1.16M
Income tax
--0.00
--0.00
Income after tax
---2.42M
---1.16M
Net income from continuous operations
---2.42M
---1.16M
Net income attributable to controlling interests
---2.42M
---856.33K
Net income attributable to common shareholders
---2.42M
---856.33K
Basic earnings per share
---0.22
---0.11
Diluted earnings per share
---0.22
---0.11
Dividend per share
--0.00
--0.00
Currency unit
USD
USD
Audit opinions
--
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.